logo
Search orAI Icon𝛼SK
ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

251
Analysis
Health Care • United States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
bearish•Actelion Ltd
•26 May 2017 16:00

Actelion / Johnson & Johnson: Tendered Vs Untendered Lines

Any deal-threatening risks to the Actelion / Johnson & Johnson transaction were assuaged in late March and we now solely await EC antitrust...

Logo
Share
bullish•Thematic (Sector/Industry)
•28 Apr 2017 14:09

The Week That Was in NorthAsia@Smartkarma - THAAD Deployment, Mobile Lineage, and Activism in Japan

KoreaScott Laprise/ 乐天虎 and Prasenjit K. Basu have provided great insights regarding the political turmoil surrounding North Korea. Scott makes it...

Logo
Douglas Kim
401 Views
Share
bearish•Celltrion Inc
•22 Apr 2017 02:17

The Disconnect Is Growing

Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...

Logo
Share
bearish•Thematic (Sector/Industry)
•17 Apr 2017 06:55

The Week That Was in NorthAsia@Smartkarma: Toshiba, Peptidream, and Missiles

It's been a full week for coverage of North Asia on Smartkarma. 30-odd insights on Japan and a dozen on Korea.ToshibaThe big theme of the week, and...

Logo
Mio Kato
462 Views
Share
bullish•Peptidream Inc
•11 Apr 2017 21:53

PeptiDream: J&J Latest Drug Major to Tie Up

On the surface, Peptidream's (4587 JP) deal with Johnson & Johnson's (JNJ US) Janssen unit looks no different from the deals they have cut with...

Logo
Share

Copyright Š 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x